Open AccessSorafenib + Standard Chemotherapy in Pediatric Patients With FLT3/ITD+ AML
Author(s) -
Dibash Kumar Das
Publication year - 2022
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000899264.16618.52
Subject(s) - sorafenib , medicine , chemotherapy , oncology , fms like tyrosine kinase 3 , chemotherapy regimen , mutation , hepatocellular carcinoma , biochemistry , chemistry , gene